WallStreetZenWallStreetZen

NASDAQ: KRYS
Krystal Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KRYS

Based on 6 analysts offering 12 month price targets for Krystal Biotech Inc.
Min Forecast
$160.00-2.5%
Avg Forecast
$185.67+13.14%
Max Forecast
$204.00+24.31%

Should I buy or sell KRYS stock?

Based on 6 analysts offering ratings for Krystal Biotech Inc.
Strong Buy
Strong Buy
5 analysts 83.33%
Buy
1 analysts 16.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KRYS stock forecasts and price targets.

KRYS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-08
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-02-27Find Out Why
lockedlocked$00.00+00.00%2024-02-27Find Out Why
lockedlocked$00.00+00.00%2023-12-13
Goldman Sachs
Bottom 5%
5
Strong BuyInitiates Coverage On$160.00-2.50%2023-11-20

1 of 1

Forecast return on equity

Is KRYS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.39%

Forecast return on assets

Is KRYS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KRYS revenue forecast

What is KRYS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$240.8M+150.95%
Avg 2 year Forecast
$371.2M+286.84%
Avg 3 year Forecast
$445.3M+364.15%
KRYS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KRYS earnings growth forecast

How is KRYS forecast to perform vs Biotechnology companies and vs the US market?
Company
-10.28%
Industry
8.89%
Market
18.2%
KRYS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
KRYS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
KRYS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

KRYS revenue growth forecast

How is KRYS forecast to perform vs Biotechnology companies and vs the US market?
Company
67.97%
Industry
37.19%
Market
9.95%
KRYS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KRYS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KRYS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRYS$164.10$185.67+13.14%Strong Buy
MDGL$220.06$345.09+56.82%Buy
CRSP$56.22$80.50+43.19%Buy
NUVL$70.88$101.43+43.10%Strong Buy
IMVT$30.70$51.33+67.21%Strong Buy
View Top Biotech Stocks

Krystal Biotech Stock Forecast FAQ

Is Krystal Biotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: KRYS) stock is to Strong Buy KRYS stock.

Out of 6 analysts, 5 (83.33%) are recommending KRYS as a Strong Buy, 1 (16.67%) are recommending KRYS as a Buy, 0 (0%) are recommending KRYS as a Hold, 0 (0%) are recommending KRYS as a Sell, and 0 (0%) are recommending KRYS as a Strong Sell.

If you're new to stock investing, here's how to buy Krystal Biotech stock.

What is KRYS's revenue growth forecast for 2024-2026?

(NASDAQ: KRYS) Krystal Biotech's forecast annual revenue growth rate of 67.97% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Krystal Biotech's revenue in 2024 is $95,949,000.On average, 3 Wall Street analysts forecast KRYS's revenue for 2024 to be $6,876,301,183, with the lowest KRYS revenue forecast at $5,583,175,020, and the highest KRYS revenue forecast at $7,716,490,488. On average, 3 Wall Street analysts forecast KRYS's revenue for 2025 to be $10,600,036,175, with the lowest KRYS revenue forecast at $7,168,168,440, and the highest KRYS revenue forecast at $13,531,274,456.

In 2026, KRYS is forecast to generate $12,718,301,345 in revenue, with the lowest revenue forecast at $8,404,748,892 and the highest revenue forecast at $15,528,080,581.

What is KRYS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KRYS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KRYS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year KRYS price target, the average KRYS price target is $185.67, with the highest KRYS stock price forecast at $204.00 and the lowest KRYS stock price forecast at $160.00.

On average, Wall Street analysts predict that Krystal Biotech's share price could reach $185.67 by May 8, 2025. The average Krystal Biotech stock price prediction forecasts a potential upside of 13.14% from the current KRYS share price of $164.10.

What is KRYS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KRYS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.